| __timestamp | Geron Corporation | Walgreens Boots Alliance, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 16758000 | 17992000000 |
| Thursday, January 1, 2015 | 17793000 | 22400000000 |
| Friday, January 1, 2016 | 18761000 | 23910000000 |
| Sunday, January 1, 2017 | 19287000 | 23813000000 |
| Monday, January 1, 2018 | 18707000 | 24694000000 |
| Tuesday, January 1, 2019 | 20893000 | 23557000000 |
| Wednesday, January 1, 2020 | 25678000 | 25436000000 |
| Friday, January 1, 2021 | 29665000 | 24586000000 |
| Saturday, January 1, 2022 | 43628000 | 27295000000 |
| Sunday, January 1, 2023 | 69135000 | 34205000000 |
| Monday, January 1, 2024 | 28113000000 |
Infusing magic into the data realm
In the competitive world of corporate finance, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Walgreens Boots Alliance, Inc. and Geron Corporation present a fascinating study in contrasts. From 2014 to 2023, Walgreens consistently maintained SG&A expenses around $23 billion to $25 billion, reflecting a stable cost management strategy. In contrast, Geron Corporation's SG&A expenses surged by over 300%, from approximately $17 million in 2014 to nearly $69 million in 2023. This dramatic increase suggests a strategic shift or expansion efforts by Geron. While Walgreens' expenses are significantly higher in absolute terms, their stability over the years indicates effective cost control relative to their scale. As we look to 2024, Walgreens projects a further increase, while Geron's data remains elusive, leaving room for speculation on their future financial strategies.
Selling, General, and Administrative Costs: Novartis AG vs Walgreens Boots Alliance, Inc.
Sarepta Therapeutics, Inc. vs Walgreens Boots Alliance, Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Walgreens Boots Alliance, Inc. vs Ascendis Pharma A/S
Walgreens Boots Alliance, Inc. and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
Walgreens Boots Alliance, Inc. and Catalyst Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Walgreens Boots Alliance, Inc. vs Alkermes plc
Operational Costs Compared: SG&A Analysis of Walgreens Boots Alliance, Inc. and Veracyte, Inc.
Operational Costs Compared: SG&A Analysis of Walgreens Boots Alliance, Inc. and Perrigo Company plc
Cost Management Insights: SG&A Expenses for Cytokinetics, Incorporated and Geron Corporation
Cost Management Insights: SG&A Expenses for ACADIA Pharmaceuticals Inc. and Geron Corporation
Who Optimizes SG&A Costs Better? Geron Corporation or Wave Life Sciences Ltd.